Treatment of degenerative diseases with the x-linked...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 48/00 (2006.01) A61K 31/7088 (2006.01) A61K 35/12 (2006.01) A61K 38/17 (2006.01) A61P 1/16 (2006.01) A61P 9/00 (2006.01) A61P 21/00 (2006.01) A61P 27/02 (2006.01)

Patent

CA 2595942

Methods and compositions comprising vectors expressing XIAP or XIAP protein preparations for the treatment of degenerative disorders including retinal degeneration, skeletal muscular atrophy, spmal muscular atrophy (SMA), spmobulbar muscular atrophy (SBMA), amyolateral sclerosis (ALS), muscular dystrophy, Parkinson's disease, cardiac injury, and liver disease, and for the reduction of cell apoptosis during transplantation of cells are provided.

Cette invention concerne des méthodes et des compositions comprenant des vecteurs exprimant XIAP ou des préparations protéiques de XIAP et servant au traitement de troubles dégénératifs tels que la dégénérescence rétinienne, l'amyotrophie du squelette, l'amyotrophie spinale (SMA), l'amyotrophie spinobulbaire (SBMA), la sclérose amyolatérale (ALS), la dystrophie musculaire, la maladie de Parkinson, la lésion cardiaque et la maladie hépatique, et à la réduction de l'apoptose cellulaire lors de la transplantation de cellules.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of degenerative diseases with the x-linked... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of degenerative diseases with the x-linked..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of degenerative diseases with the x-linked... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1375687

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.